Molecular Cancer Therapeutics Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Other Issues:
Contents: January 1 2004, Volume 3, Issue 1   [Index by Author]  [Cover Caption]
       Articles
       Corrections
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Articles:

Chafiq Hamdouchi, Heather Keyser, Elizabeth Collins, Carlos Jaramillo, Jose Eugenio De Diego, Charles D. Spencer, Jack Alan Dempsey, Bryan D. Anderson, Tillie Leggett, Nancy B. Stamm, Richard M. Schultz, Scott A. Watkins, Kim Cocke, Stephanie Lemke, Teresa F. Burke, Richard P. Beckmann, Jeffrey T. Dixon, Thomas M. Gurganus, Nancy B. Rankl, Keith A. Houck, Faming Zhang, Michal Vieth, Juan Espinosa, David E. Timm, Robert M. Campbell, Bharvin K. R. Patel, and Harold B. Brooks
The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridines
Mol Cancer Ther 2004 3: 1-9. [Abstract] [Full Text] [PDF]  

Beverly E. Barton, James G. Karras, Thomas F. Murphy, Arnold Barton, and Hosea F-S. Huang
Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines
Mol Cancer Ther 2004 3: 11-20. [Abstract] [Full Text] [PDF]  

Maria Nunes, Celine Shi, and Lee M. Greenberger
Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes
Mol Cancer Ther 2004 3: 21-27. [Abstract] [Full Text] [PDF]  

Tomohiko Mori, Ryuichiro Doi, Masayuki Koizumi, Eiji Toyoda, Daisuke Ito, Kazuhiro Kami, Toshihiko Masui, Koji Fujimoto, Hirokazu Tamamura, Kenichi Hiramatsu, Nobutaka Fujii, and Masayuki Imamura
CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer
Mol Cancer Ther 2004 3: 29-37. [Abstract] [Full Text] [PDF]  

Takashi Ikeda, Yukiko Nakata, Fumihiko Kimura, Ken Sato, Kenneth Anderson, Kazuo Motoyoshi, Michael Sporn, and Donald Kufe
Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid
Mol Cancer Ther 2004 3: 39-45. [Abstract] [Full Text] [PDF]  

Darshan S. Sappal, A. Kathleen McClendon, James A. Fleming, Vala Thoroddsen, Kelly Connolly, Corinne Reimer, Ronald K. Blackman, Christine E. Bulawa, Neil Osheroff, Peter Charlton, and Laura A. Rudolph-Owen
Biological characterization of MLN944: A potent DNA binding agent
Mol Cancer Ther 2004 3: 47-58. [Abstract] [Full Text] [PDF]  

Steffan T. Nawrocki, Bridget Sweeney-Gotsch, Ryan Takamori, and David J. McConkey
The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts
Mol Cancer Ther 2004 3: 59-70. [Abstract] [Full Text] [PDF]  

Ali R. Jazirehi and Benjamin Bonavida
Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis
Mol Cancer Ther 2004 3: 71-84. [Abstract] [Full Text] [PDF]  

Takashi Kurizaki, Michio Abe, Sam D. Sanderson, Charles A. Enke, and Janina Baranowska-Kortylewicz
Role of polymorphonuclear leukocytes, nitric oxide synthase, and cyclooxygenase in vascular permeability changes induced by C5a agonist peptides
Mol Cancer Ther 2004 3: 85-91. [Abstract] [Full Text] [PDF]  

Shoichiro Ohtani, Shunsuke Kagawa, Yasuhisa Tango, Tatsuo Umeoka, Naoyuki Tokunaga, Yousuke Tsunemitsu, Jack A. Roth, Yoichi Taya, Noriaki Tanaka, and Toshiyoshi Fujiwara
Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo
Mol Cancer Ther 2004 3: 93-100. [Abstract] [Full Text] [PDF]  

Corrections:

Correction
Mol Cancer Ther 2004 3: 101. [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.